AustralieFrV1, PascalFrancis, Checkpoint, bibRecord, 005F12

Sea anemone toxins as templates for the design of immunosuppressant drugs

Identifieur interne : 005F12 ( PascalFrancis/Checkpoint ); précédent : 005F11; suivant : 005F13

Sea anemone toxins as templates for the design of immunosuppressant drugs

Auteurs : W. R. Kem [États-Unis] ; M. W. Pennington [États-Unis] ; R. S. Norton [Australie]

Source :

Perspectives in drug discovery and design [ 0928-2866 ] ; 1999.

RBID : Pascal:99-0408262

Descripteurs français

Pascal (Inist)
- Toxine, Peptide, Canal ionique, Potassium Cation, Lymphocyte T, Immunodépresseur, Interaction moléculaire, Maladie autoimmune, Activité biologique, Article synthèse, Activation, Analyse structurale, Structure 3 dimensions.

English descriptors

KwdEn :
- Activation, Autoimmune disease, Biological activity, Immunosuppressive agent, Ionic channel, Molecular interaction, Peptides, Potassium Cations, Review, Structural analysis, T-Lymphocyte, Three dimensional structure, Toxin.

Affiliations:

Australie, États-Unis

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 006285
to stream PascalFrancis, to step Curation: 006D69

Links to Exploration step

Pascal:99-0408262

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Sea anemone toxins as templates for the design of immunosuppressant drugs</title>
<author><name sortKey="Kem, W R" sort="Kem, W R" uniqKey="Kem W" first="W. R." last="Kem">W. R. Kem</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Pharmacology and Therapeutics, University of Florida College of Medicine</s1>
<s2>Gainesville, FL 32610-026</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Gainesville, FL 32610-026</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pennington, M W" sort="Pennington, M W" uniqKey="Pennington M" first="M. W." last="Pennington">M. W. Pennington</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Bachem Bioscience Inc., 3700 Horizon Drive</s1>
<s2>King of Prussia, PA 19406</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>King of Prussia, PA 19406</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Norton, R S" sort="Norton, R S" uniqKey="Norton R" first="R. S." last="Norton">R. S. Norton</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Biomolecular Research Institute, 343 Royal Parade</s1>
<s2>Parkville, VIC 3052</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Parkville, VIC 3052</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">99-0408262</idno>
<date when="1999">1999</date>
<idno type="stanalyst">PASCAL 99-0408262 INIST</idno>
<idno type="RBID">Pascal:99-0408262</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">006285</idno>
<idno type="wicri:Area/PascalFrancis/Curation">006D69</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">005F12</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">005F12</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Sea anemone toxins as templates for the design of immunosuppressant drugs</title>
<author><name sortKey="Kem, W R" sort="Kem, W R" uniqKey="Kem W" first="W. R." last="Kem">W. R. Kem</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Pharmacology and Therapeutics, University of Florida College of Medicine</s1>
<s2>Gainesville, FL 32610-026</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Gainesville, FL 32610-026</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pennington, M W" sort="Pennington, M W" uniqKey="Pennington M" first="M. W." last="Pennington">M. W. Pennington</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Bachem Bioscience Inc., 3700 Horizon Drive</s1>
<s2>King of Prussia, PA 19406</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>King of Prussia, PA 19406</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Norton, R S" sort="Norton, R S" uniqKey="Norton R" first="R. S." last="Norton">R. S. Norton</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Biomolecular Research Institute, 343 Royal Parade</s1>
<s2>Parkville, VIC 3052</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Parkville, VIC 3052</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Perspectives in drug discovery and design</title>
<title level="j" type="abbreviated">Perspect. drug discov. des.</title>
<idno type="ISSN">0928-2866</idno>
<imprint><date when="1999">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Perspectives in drug discovery and design</title>
<title level="j" type="abbreviated">Perspect. drug discov. des.</title>
<idno type="ISSN">0928-2866</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Activation</term>
<term>Autoimmune disease</term>
<term>Biological activity</term>
<term>Immunosuppressive agent</term>
<term>Ionic channel</term>
<term>Molecular interaction</term>
<term>Peptides</term>
<term>Potassium Cations</term>
<term>Review</term>
<term>Structural analysis</term>
<term>T-Lymphocyte</term>
<term>Three dimensional structure</term>
<term>Toxin</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Toxine</term>
<term>Peptide</term>
<term>Canal ionique</term>
<term>Potassium Cation</term>
<term>Lymphocyte T</term>
<term>Immunodépresseur</term>
<term>Interaction moléculaire</term>
<term>Maladie autoimmune</term>
<term>Activité biologique</term>
<term>Article synthèse</term>
<term>Activation</term>
<term>Analyse structurale</term>
<term>Structure 3 dimensions</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0928-2866</s0>
</fA01>
<fA03 i2="1"><s0>Perspect. drug discov. des.</s0>
</fA03>
<fA05><s2>15-16</s2>
</fA05>
<fA08 i1="01" i2="1" l="ENG"><s1>Sea anemone toxins as templates for the design of immunosuppressant drugs</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Animal Toxins and Potassium Channels</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>KEM (W. R.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>PENNINGTON (M. W.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>NORTON (R. S.)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>DARBON (Hervé)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1"><s1>SABATIER (Jean-Marc)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01"><s1>Department of Pharmacology and Therapeutics, University of Florida College of Medicine</s1>
<s2>Gainesville, FL 32610-026</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Bachem Bioscience Inc., 3700 Horizon Drive</s1>
<s2>King of Prussia, PA 19406</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Biomolecular Research Institute, 343 Royal Parade</s1>
<s2>Parkville, VIC 3052</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Architecture et Fonction des Macromolécules Biologiques (AFMB), Centre National de la Recherche Scientifique, UPR 9039, IFR 1, 31 Chemin Joseph Aiguier</s1>
<s2>13402 Marseille</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</fA15>
<fA15 i1="02"><s1>Laboratoire de Biochimie, Faculté de Médecine Nord</s1>
<s2>13916 Marseille</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA15>
<fA20><s1>111-129</s1>
</fA20>
<fA21><s1>1999</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>21308S</s2>
<s5>354000085546110070</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 1999 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>53 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>99-0408262</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Perspectives in drug discovery and design</s0>
</fA64>
<fA66 i1="01"><s0>NLD</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B02Q</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Toxine</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Toxin</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Toxina</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Peptide</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Peptides</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Péptido</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Canal ionique</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Ionic channel</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Canal iónico</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Potassium Cation</s0>
<s2>NC</s2>
<s2>FR</s2>
<s2>NA</s2>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Potassium Cations</s0>
<s2>NC</s2>
<s2>FR</s2>
<s2>NA</s2>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Potasio Cation</s0>
<s2>NC</s2>
<s2>FR</s2>
<s2>NA</s2>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Lymphocyte T</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>T-Lymphocyte</s0>
<s5>11</s5>
<s6>«T»-Lymphocyte</s6>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Linfocito T</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Immunodépresseur</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Immunosuppressive agent</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Inmunodepresor</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Interaction moléculaire</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Molecular interaction</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Interacción molecular</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Maladie autoimmune</s0>
<s5>16</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Autoimmune disease</s0>
<s5>16</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Enfermedad autoinmune</s0>
<s5>16</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Activité biologique</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Biological activity</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Actividad biológica</s0>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Article synthèse</s0>
<s5>18</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Review</s0>
<s5>18</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Artículo síntesis</s0>
<s5>18</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Activation</s0>
<s5>19</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Activation</s0>
<s5>19</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Activación</s0>
<s5>19</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Analyse structurale</s0>
<s5>20</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Structural analysis</s0>
<s5>20</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Análisis estructural</s0>
<s5>20</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Structure 3 dimensions</s0>
<s5>21</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Three dimensional structure</s0>
<s5>21</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Estructura 3 dimensiones</s0>
<s5>21</s5>
</fC03>
<fN21><s1>263</s1>
</fN21>
</pA>
</standard>
</inist>
<affiliations><list><country><li>Australie</li>
<li>États-Unis</li>
</country>
</list>
<tree><country name="États-Unis"><noRegion><name sortKey="Kem, W R" sort="Kem, W R" uniqKey="Kem W" first="W. R." last="Kem">W. R. Kem</name>
</noRegion>
<name sortKey="Pennington, M W" sort="Pennington, M W" uniqKey="Pennington M" first="M. W." last="Pennington">M. W. Pennington</name>
</country>
<country name="Australie"><noRegion><name sortKey="Norton, R S" sort="Norton, R S" uniqKey="Norton R" first="R. S." last="Norton">R. S. Norton</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005F12 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 005F12 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    RBID
   |clé=     Pascal:99-0408262
   |texte=   Sea anemone toxins as templates for the design of immunosuppressant drugs
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Sea anemone toxins as templates for the design of immunosuppressant drugs

Sea anemone toxins as templates for the design of immunosuppressant drugs

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri